All Stories

  1. Using a generative co-design framework to adapt an exercise intervention as part of a multimodal intervention for patients’ receiving haemodialysis with or at risk of renal cachexia
  2. Anti-inflammatory effects and safety of omega-3 fatty acids in haemodialysis: A systematic review and meta-analysis
  3. Multi-modal integrated intervention combining exercise, anti-inflammatory, and dietary advice (MMIEAD) for adults with kidney cachexia: protocol for a mixed-methods feasibility cluster randomised controlled trial and process evaluation
  4. Exploring Telomere Association in Donor–Recipient Pairs: Implications for Kidney Graft Longevity
  5. Blood DNA methylation markers are associated with diabetic kidney disease progression in type 1 diabetes
  6. Variation in Attitudes to Native Kidney Biopsy Practice in the United States
  7. Immune cell subsets in young kidney transplant recipients: Mechanistic and clinical perspectives
  8. Exome-Wide Analysis Identifies a Rare EXD3 Missense Variant Associated With Diabetic Kidney Disease
  9. The Association of Socioeconomic Status on Kidney Transplant Access and Outcomes: Cohort Studies of England and Northern Ireland
  10. Low circulating miR-190a-5p predicts progression of chronic kidney disease
  11. Large Language Models’ Clinical Decision-Making on When to Perform a Kidney Biopsy: Comparative Study
  12. Duke activity status index is not predictive of outcomes after kidney transplantation: a retrospective observational study
  13. Effects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial
  14. James Frederick Douglas
  15. Genome-Wide Association Study of Quantitative Kidney Function in 52,531 Individuals with Diabetes Identifies Five Diabetes-Specific Loci
  16. Can large language models’ clinical decision-making match human consensus on when to perform a kidney biopsy? (Preprint)
  17. Donor and Recipient Polygenic Risk Scores Influence Kidney Transplant Function
  18. Polygenic risk scores for eGFR are associated with age at kidney failure
  19. Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease
  20. Systematic review of the application of the Kidney Failure Risk Equation and Oxford classification in estimating prognosis in IgA Nephropathy
  21. Non-adherence to immunosuppressive medications in kidney transplant recipients- a systematic scoping review
  22. An International Study of Variation in Attitudes to Kidney Biopsy Practice
  23. The lived experience of renal cachexia: An interpretive phenomenological analysis
  24. Blood methylation biomarkers are associated with diabetic kidney disease progression in type 1 diabetes
  25. Systematic review of the application of the Kidney Failure Equation and Oxford classification in estimating prognosis in IgA Nephropathy
  26. A Novel Role for FERM Domain-Containing Protein 3 in CKD
  27. Does Live Donor and Preemptive Kidney Transplantation Reduce the Impact of Socioeconomic Deprivation on Graft Outcome?
  28. Nonadherence to Immunosuppressive Medications in Kidney Transplant Recipients: A Systematic Scoping Review
  29. ‘Was my kidney biopsy worth it?’–A qualitative phenomenological study of patient experiences and perceived barriers to kidney biopsy
  30. Mitochondrial related variants associated with cardiovascular traits
  31. Frailty, Multimorbidity, and Polypharmacy
  32. Genetic variants affecting mitochondrial function provide further insights for kidney disease
  33. Donor genetic burden for cerebrovascular risk and kidney transplant outcome
  34. Shared genetic features between lymphoma pathogenesis and oestrogen levels
  35. Protocol for a systematic review of the application of the kidney failure risk equation and Oxford classification in estimating prognosis in IgA nephropathy
  36. Genetic and Epigenetic Associations with Post-Transplant Diabetes Mellitus
  37. Latest advances in frailty in kidney transplantation: A narrative review
  38. Low circulating miR-190a-5p predicts progression of chronic kidney disease.
  39. Striking fear into students’ hearts: Unforeseen consequences of prescribing education
  40. Protocol for a Systematic review of the application of the Kidney Failure Risk Equation and Oxford classification in estimating prognosis in IgA Nephropathy
  41. Proteomic analysis investigating kidney transplantation outcomes- a scoping review
  42. Safety and Preliminary Efficacy of Mesenchymal Stromal Cell (ORBCEL-M) Therapy in Diabetic Kidney Disease: A Randomized Clinical Trial (NEPHSTROM)
  43. Albuminuria-Related Genetic Biomarkers: Replication and Predictive Evaluation in Individuals with and without Diabetes from the UK Biobank
  44. #3022 REDUCED TUBULAR MIR-190A-5P: A NOVEL BIOMARKER FOR STRATIFICATION OF PATIENTS WITH CHRONIC KIDNEY DISEASE
  45. Differential Methylation of Telomere-Related Genes Is Associated with Kidney Disease in Individuals with Type 1 Diabetes
  46. A genome-wide association study identifies a possible role for cannabinoid signalling in the pathogenesis of diabetic kidney disease
  47. Harnessing Genomic Analysis to Explore the Role of Telomeres in the Pathogenesis and Progression of Diabetic Kidney Disease
  48. Longitudinal Epigenome-Wide Analysis of Kidney Transplant Recipients Pretransplant and Posttransplant
  49. Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy
  50. Empagliflozin in Patients with Chronic Kidney Disease
  51. Early clinical and economic outcomes of expanded criteria living kidney donors in the United States
  52. Epigenome-wide meta-analysis identifies DNA methylation biomarkers associated with diabetic kidney disease
  53. Developing an Evidence and Theory Based Multimodal Integrative Intervention for the Management of Renal Cachexia: A Theory of Change
  54. Mesenchymal stromal cell therapy compared to SGLT2-inhibitors and usual care in treating diabetic kidney disease: A cost-effectiveness analysis
  55. Exploring the lived experience of renal cachexia for individuals with end-stage renal disease and the interrelated experience of their carers: Study protocol
  56. An Analysis of Vascular Access Thrombosis Events From the Proactive IV irOn Therapy in hemodiALysis Patients Trial
  57. Genome-wide meta-analysis and omics integration identifies novel genes associated with diabetic kidney disease
  58. Harnessing the Full Potential of Multi-Omic Analyses to Advance the Study and Treatment of Chronic Kidney Disease
  59. Dialysis, Distress, and Difficult Conversations: Living with a Kidney Transplant
  60. Clinical features and predictive biomarkers for bladder cancer in patients with type 2 diabetes presenting with haematuria
  61. Polycystic Kidney Disease
  62. Stroke in Hemodialysis Patients Randomized to Different Intravenous Iron Strategies: A Prespecified Analysis from the PIVOTAL Trial
  63. Experiences of renal healthcare practitioners during the COVID-19 pandemic: a multi-methods approach
  64. 57 th EASD Annual Meeting of the European Association for the Study of Diabetes
  65. Genome-wide meta-analysis and omics integration identifies novel genes associated with diabetic kidney disease
  66. Retinal microvascular parameters are not associated with diabetes in the Northern Ireland Cohort for the Longitudinal Study of Ageing
  67. Association of renal impairment with cognitive dysfunction in the Northern Ireland Cohort for the Longitudinal Study of Ageing (NICOLA)
  68. Dietary patterns associated with renal impairment in the Northern Ireland Cohort for the Longitudinal Study of Ageing (NICOLA)
  69. Assessment of differentially methylated loci in individuals with end-stage kidney disease attributed to diabetic kidney disease: an exploratory study
  70. The effects of vitamin E supplementation on malondialdehyde as a biomarker of oxidative stress in haemodialysis patients: a systematic review and meta-analysis
  71. Retinal microvascular parameters are not significantly associated with mild cognitive impairment in the Northern Ireland Cohort for the Longitudinal Study of Ageing
  72. A Critical Review of Multimodal Interventions for Cachexia
  73. A systematic review and participant-level meta-analysis found little association of retinal microvascular caliber with reduced kidney function
  74. Erratum
  75. Investigation of associations between retinal microvascular parameters and albuminuria in UK Biobank: a cross-sectional case-control study
  76. Association of reduced retinal arteriolar tortuosity with depression in older participants from the Northern Ireland Cohort for the Longitudinal Study of Ageing
  77. Variation in retinal microvascular parameters is associated with mild cognitive impairment and Alzheimer’s disease
  78. Nurse-led advance care planning with older people who have end-stage kidney disease: feasibility of a deferred entry randomised controlled trial incorporating an economic evaluation and mixed methods process evaluation (ACReDiT)
  79. Using a generic definition of cachexia in patients with kidney disease receiving haemodialysis: a longitudinal (pilot) study
  80. DNA Methylation Associated With Diabetic Kidney Disease in Blood-Derived DNA
  81. The role of motivational and legal contexts in understanding support for tissue donation across 27 European countries
  82. Prospective payment system and racial/ethnic disparities: a national retrospective observational study in anaemia complication among end-stage renal disease patients in the US
  83. Abstracts
  84. Quality of life in advanced renal disease managed either by haemodialysis or conservative care in older patients
  85. Association of retinal venular tortuosity with impaired renal function in the Northern Ireland Cohort for the Longitudinal Study of Ageing
  86. Assessment of differentially methylated loci in individuals with end-stage kidney disease attributed to diabetic kidney disease
  87. The Potential of Albuminuria as a Biomarker of Diabetic Complications
  88. Estimating the Prevalence of Muscle Wasting, Weakness, and Sarcopenia in Hemodialysis Patients
  89. Understanding the holistic experiences of living with a kidney transplant: an interpretative phenomenological study (protocol)
  90. Utility of Phase Angle to Identify Cachexia and Assess Mortality in End-Stage Renal Disease
  91. Hyperamylasemia Post Living Donor Nephrectomy Does Not Relate to Pain
  92. “Mitochondrial Toolbox” – A Review of Online Resources to Explore Mitochondrial Genomics
  93. Intravenous Iron Dosing and Infection Risk in Patients on Hemodialysis: A Prespecified Secondary Analysis of the PIVOTAL Trial
  94. The impact of chronic kidney disease on developed countries from a health economics perspective: A systematic scoping review
  95. Genome-wide association study on coronary artery disease in type 1 diabetes suggests beta-defensin 127 as a risk locus
  96. Association of reduced inner retinal thicknesses with chronic kidney disease
  97. Association of soluble ST2 with all-cause and cardiovascular mortality in renal transplant recipients: a single-centre cohort study
  98. Evaluation of long-term intravitreal anti-vascular endothelial growth factor injections on renal function in patients with and without diabetic kidney disease
  99. Comparison of methylation patterns generated from genomic and cell-line derived DNA using the Illumina Infinium MethylationEPIC BeadChip array
  100. Serum xanthophyll carotenoids are associated with estimated glomerular filtration rate in an aged cohort
  101. Awareness, Understanding and Treatment Practices when Managing Cachexia in End‐Stage Kidney Disease
  102. Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen
  103. The Challenges of Chromosome Y Analysis and the Implications for Chronic Kidney Disease
  104. Differential methylation as a diagnostic biomarker of rare renal diseases: a systematic review
  105. Genetic renal disorders
  106. Differential Expression of Urinary Exosomal MicroRNAs miR-21-5p and miR-30b-5p in Individuals with Diabetic Kidney Disease
  107. Identifying Malnutrition in End-stage Renal Disease (ESRD) (P12-037-19)
  108. Genetic Susceptibility to Chronic Kidney Disease – Some More Pieces for the Heritability Puzzle
  109. Genomic Mismatch at LIMS1 Locus and Kidney Allograft Rejection
  110. Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
  111. Genetic associations between genes in the renin-angiotensin-aldosterone system and renal disease: a systematic review and meta-analysis
  112. The impact of donor and recipient common clinical and genetic variation on estimated glomerular filtration rate in a European renal transplant population
  113. Serum amyloid A levels are associated with polymorphic variants in the serum amyloid A 1 and 2 genes
  114. Proteomic and metabolomic approaches in the search for biomarkers in chronic kidney disease
  115. Long-Term Outcomes of Renal Transplant in Recipients With Lower Urinary Tract Dysfunction
  116. Intravenous Iron in Patients Undergoing Maintenance Hemodialysis
  117. Mitochondria and Chronic Kidney Disease: A Molecular Update
  118. Genome-wide association study of diabetic kidney disease highlights biology involved in renal basement membrane collagen
  119. Risk prediction for acute kidney injury in acute medical admissions in the UK
  120. Chronic kidney disease, health-related quality of life and their associated economic burden among a nationally representative sample of community dwelling adults in England
  121. Cardiovascular risk in renal transplant recipients
  122. Advance Care Planning With Patients Who Have End-Stage Kidney Disease: A Systematic Realist Review
  123. Validation of differentially methylated microRNAs identified from an epigenome-wide association study; Sanger and next generation sequencing approaches
  124. Genomic approaches in the search for molecular biomarkers in chronic kidney disease
  125. Polygenic risk score as a determinant of risk of non-melanoma skin cancer in a European-descent renal transplant cohort
  126. Quality of life with conservative care compared with assisted peritoneal dialysis and haemodialysis
  127. Healthcare use, costs and quality of life in patients with end-stage kidney disease receiving conservative management: results from a multi-centre observational study (PACKS)
  128. A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes
  129. Dietary patterns and chronic kidney disease: a cross-sectional association in the Irish Nun Eye Study
  130. Novel risk genes identified in a genome-wide association study for coronary artery disease in patients with type 1 diabetes
  131. Retinal microvascular parameters are not associated with reduced renal function in a study of individuals with type 2 diabetes
  132. Establishing a clinical phenotype for cachexia in end stage kidney disease – study protocol
  133. Long- and short-term outcomes in renal allografts with deceased donors: A large recipient and donor genome-wide association study
  134. Arterial stiffness alone does not explain arteriovenous fistula outcomes
  135. Dietary Patterns and Retinal Vessel Caliber in the Irish Nun Eye Study
  136. Treatment effects of renin-angiotensin aldosterone system blockade on kidney failure and mortality in chronic kidney disease patients
  137. Learning to prescribe intravenous fluids: A scoping review
  138. Estimated Glomerular Filtration Rate is not Associated with Alzheimer’s Disease in a Northern Ireland Cohort
  139. Design and implementation of a custom next generation sequencing panel for selected vitamin D associated genes
  140. Development of next generation sequencing panel for UMOD and association with kidney disease
  141. Clinician views of patient decisional conflict when deciding between dialysis and conservative management: Qualitative findings from the PAlliative Care in chronic Kidney diSease (PACKS) study
  142. High-volume haemofiltration for sepsis in adults
  143. Type 2 Diabetes in Young Females Results in Increased Serum Amyloid A and Changes to Features of High Density Lipoproteins in Both HDL2 and HDL3
  144. Distinguishing Between Cachexia, Sarcopenia and Protein Energy Wasting in End-Stage Renal Disease Patients on Dialysis
  145. The Genetic Landscape of Renal Complications in Type 1 Diabetes
  146. A Rare Cause of Myoclonus
  147. Wnt6 regulates epithelial cell differentiation and is dysregulated in renal fibrosis
  148. Analysis of single nucleotide polymorphisms implicate mTOR signalling in the development of new-onset diabetes after transplantation
  149. Orals
  150. Evidence for three genetic loci involved in both anorexia nervosa risk and variation of body mass index
  151. EAPC2016: Abstracts
  152. Correction
  153. Does the co-existence of acute anterior uveitis and chronic back pain prompt primary care physicians to consider a diagnosis of axial spondyloarthritis?
  154. Arterial Stiffness and Arteriovenous Fistula Failure of Maturation
  155. Preoperative radial artery volume flow is predictive of arteriovenous fistula outcomes
  156. A HuGE Review and Meta-Analyses of Genetic Associations in New Onset Diabetes after Kidney Transplantation
  157. Bioinformatic Evaluation of Transcriptional Regulation of WNT Pathway Genes with reference to Diabetic Nephropathy
  158. Ethical reasoning through simulation: a phenomenological analysis of student experience
  159. Quality of Life and Physical Function in Older Patients on Dialysis: A Comparison of Assisted Peritoneal Dialysis with Hemodialysis
  160. Investigating clinical predictors of arteriovenous fistula functional patency in a European cohort
  161. Arteriovenous fistula outcomes in the elderly
  162. Evaluation of the Retinal Vasculature in Hypertension and Chronic Kidney Disease in an Elderly Population of Irish Nuns
  163. Genetic Evidence for a Causal Role of Obesity in Diabetic Kidney Disease
  164. PAlliative Care in chronic Kidney diSease: the PACKS study—quality of life, decision making, costs and impact on carers in people managed without dialysis
  165. Genetic renal abnormalities
  166. Recipient obesity and outcomes after kidney transplantation: a systematic review and meta-analysis
  167. Retinal microvascular network attenuation in Alzheimer's disease
  168. DEFINING CACHEXIA IN A RENAL POPULATION
  169. Genetics of Diabetic Nephropathy: a Long Road of Discovery
  170. Learning fluid prescription skills: why is it so challenging?
  171. Distinct methylation patterns in genes that affect mitochondrial function are associated with kidney disease in blood-derived DNA from individuals with Type 1 diabetes
  172. Genetic risk factors affecting mitochondrial function are associated with kidney disease in people with Type 1 diabetes
  173. Current tools for prediction of arteriovenous fistula outcomes
  174. Diagnosis and management of hyponatraemia: AGREEing the guidelines
  175. Genetic studies of body mass index yield new insights for obesity biology
  176. New genetic loci link adipose and insulin biology to body fat distribution
  177. Patient survival following arteriovenous fistula formation
  178. Optimizing outcomes in the elderly with end-stage renal disease—live long and prosper
  179. Retinal Vascular Caliber, Iris Color, and Age-Related Macular Degeneration in the Irish Nun Eye Study
  180. Next-generation sequencing of the mitochondrial genome and association with IgA nephropathy in a renal transplant population
  181. SORBS1 gene, a new candidate for diabetic nephropathy: results from a multi-stage genome-wide association study in patients with type 1 diabetes
  182. Analysis of data from the ERA-EDTA Registry indicates that conventional treatments for chronic kidney disease do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney disease
  183. AN APPRAISAL OF END-OF-LIFE CARE IN PERSONS WITH CHRONIC KIDNEY DISEASE DYING IN HOSPITAL WARDS
  184. Genetic and epigenetic factors influencing chronic kidney disease
  185. Factors influencing survival after kidney transplant failure
  186. Genetics and Genomics of Chronic Kidney Disease
  187. Surveillance of Nonmelanoma Skin Cancer Incidence Rates in Kidney Transplant Recipients in Ireland
  188. Preserving Arteriovenous Fistula Outcomes during Surgical Training
  189. β Cell Glucotoxic-Associated Single Nucleotide Polymorphisms in Impaired Glucose Tolerance and New-Onset Diabetes After Transplantation
  190. Treatment of choroidal neovascularisation secondary to membranoproliferative glomerulonephritis type II with intravitreal ranibizumab
  191. Genetic and Epigenetic Risk Factors for Diabetic Kidney Disease
  192. Genome-wide association study of urinary albumin excretion rate in patients with type 1 diabetes
  193. Basic and clinical science posters
  194. Type 1 diabetes and MODY
  195. Using ancestry-informative markers to identify fine structure across 15 populations of European origin
  196. Should women with diabetic nephropathy considering pregnancy continue ACE inhibitor or angiotensin II receptor blocker therapy until pregnancy is confirmed?
  197. A genome-wide association study of anorexia nervosa
  198. New onset diabetes after transplantation: unravelling the pathophysiological process
  199. Polycystic Kidney Disease
  200. Glycated Hemoglobin and Risk of Death in Diabetic Patients Treated With Hemodialysis: A Meta-analysis
  201. Estimated Glomerular Filtration Rate Decline as a Predictor of Dialysis in Kidney Transplant Recipients
  202. Genetics of New-Onset Diabetes after Transplantation
  203. DNA hypermethylation and DNA hypomethylation is present at different loci in chronic kidney disease
  204. Chronic kidney disease and diabetes in the National Health Service: a cross-sectional survey of the UK National Diabetes Audit
  205. Management of hyperkalaemia
  206. Bioinformatic Resources For Diabetic Nephropathy
  207. Chromosome 2q31.1 Associates with ESRD in Women with Type 1 Diabetes
  208. Caveolin-1 Single Nucleotide Polymorphism in Antineutrophil Cytoplasmic Antibody Associated Vasculitis
  209. Haplotype association analysis of genes within the WNT signalling pathways in diabetic nephropathy
  210. Obesity and kidney disease in type 1 and 2 diabetes: an analysis of the National Diabetes Audit
  211. CD2AP is associated with end-stage renal disease in patients with type 1 diabetes
  212. Comprehensive Investigation of the Caveolin 2 Gene: Resequencing and Association for Kidney Transplant Outcomes
  213. Association Analysis of Dyslipidemia-Related Genes in Diabetic Nephropathy
  214. Lipoxins Attenuate Renal Fibrosis by Inducing let-7c and Suppressing TGFβR1
  215. A LITERATURE REVIEW OF END-STAGE RENAL DISEASE AND CACHEXIA: UNDERSTANDING EXPERIENCE TO INFORM EVIDENCE-BASED HEALTHCARE
  216. High-volume haemofiltration for sepsis
  217. TGFβ and CCN2/CTGF mediate actin related gene expression by differential E2F1/CREB activation
  218. Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
  219. Association of Donor and Recipient Calcineurin Inhibitor Pharmacogenomic Variation with Long-Term Allograft Survival
  220. Donor ABCB1 Variant Associates with Increased Risk for Kidney Allograft Failure
  221. New Susceptibility Loci Associated with Kidney Disease in Type 1 Diabetes
  222. Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis
  223. Association of MYH9/APOL1 with chronic kidney disease in a UK population
  224. Epigenetics
  225. Association Testing of Previously Reported Variants in a Large Case-Control Meta-analysis of Diabetic Nephropathy
  226. SNP in the genome-wide association study hotspot on chromosome 9p21 confers susceptibility to diabetic nephropathy in type 1 diabetes
  227. Genetic Examination of SETD7 and SUV39H1/H2 Methyltransferases and the Risk of Diabetes Complications in Patients With Type 1 Diabetes
  228. Association analysis of proopiomelanocortin (POMC) haplotypes in type 1 diabetes in a UK population
  229. Novel Susceptibility Locus at 22q11 for Diabetic Nephropathy in Type 1 Diabetes
  230. Association Analysis of Canonical Wnt Signalling Genes in Diabetic Nephropathy
  231. ANCA-associated vasculitis is linked to carriage of the Z allele of  1 antitrypsin and its polymers
  232. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
  233. Genetic renal abnormalities
  234. Elevated soluble cellular adhesion molecules are associated with increased mortality in a prospective cohort of renal transplant recipients
  235. Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis
  236. Patterns of hospitalisation before and following initiation of haemodialysis: a 5 year single centre study
  237. Association analysis of Notch pathway signalling genes in diabetic nephropathy
  238. Managing diabetic nephropathy
  239. The finding of reduced estimated glomerular filtration rate is associated with increased mortality in a large UK population
  240. Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus
  241. Investigation of ACE, ACE2 and AGTR1 genes for association with nephropathy in Type 1 diabetes mellitus
  242. DNA methylation profiling in cell models of diabetic nephropathy
  243. Maintenance treatment of renal anaemia in haemodialysis patients with methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa administered monthly: a randomized comparative trial
  244. Advances in the Genetics of Familial Renal Cancer
  245. Association of Caveolin-1 Gene Polymorphism With Kidney Transplant Fibrosis and Allograft Failure
  246. Erythropoietin-Induced Activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK Pathways Promotes Malignant Cell Behavior in a Modified Breast Cancer Cell Line
  247. Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer
  248. Resequencing of the CCL5 and CCR5 genes and investigation of variants for association with diabetic nephropathy
  249. A GREM1 Gene Variant Associates with Diabetic Nephropathy
  250. Polymorphisms of the macrophage migration inhibitory factor gene in a UK population with Type 1 diabetes mellitus
  251. Investigation of the association of BMP gene variants with nephropathy in Type 1 diabetes mellitus
  252. Elevated Homocysteine Is a Predictor of All-Cause Mortality in a Prospective Cohort of Renal Transplant Recipients
  253. Evaluation of Five Interleukin Genes for Association with End-Stage Renal Disease in White Europeans
  254. Genetic Polymorphisms in Nitric Oxide Synthase 3 Gene and Implications for Kidney Disease: A Meta-Analysis
  255. A cautionary tale of a man with haemochromatosis, chronic kidney disease and anaemia referred for erythropoietin therapy
  256. Targeted genome-wide investigation identifies novel SNPs associated with diabetic nephropathy
  257. Revascularization versus Medical Therapy for Renal-Artery Stenosis
  258. High-volume haemofiltration for sepsis
  259. A rare haplotype of the vitamin D receptor gene is protective against diabetic nephropathy
  260. The Impact of Admissions for the Management of End-Stage Renal Disease on Hospital Bed Occupancy
  261. Association of microsatellite markers on chromosomes 6q27 region and 10p15 region with end-stage renal disease in a UK renal transplant population
  262. Replication studies based on findings from a genome-wide DNA microsatellite screen in diabetic nephropathy
  263. The changing pattern of adult primary glomerular disease
  264. Chronic kidney disease and bisphosphonate treatment: are prescribing guidelines unnecessarily restrictive?
  265. Comparative analysis of DNA methylation profiles in peripheral blood leukocytes versus lymphoblastoid cell lines
  266. The coronary artery disease SNP, rs4420638, is associated with diabetic nephropathy rather than end-stage renal disease
  267. Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
  268. Response of vulval lichen sclerosus and squamous hyperplasia to photodynamic treatment using sustained topical delivery of aminolevulinic acid from a novel bioadhesive patch system
  269. Elevated Serum Phosphate Predicts Mortality in Renal Transplant Recipients
  270. Genetic analysis of coronary artery disease single-nucleotide polymorphisms in diabetic nephropathy
  271. Annotated chromosome maps for renal disease
  272. Investigation of DNA polymorphisms in SMAD genes for genetic predisposition to diabetic nephropathy in patients with type 1 diabetes mellitus
  273. HLA antigen frequencies and Wegener's granulomatosis
  274. Unravelling the genetic basis of renal diseases; from single gene to multifactorial disorders
  275. Association of Genetic Variants at 3q22 with Nephropathy in Patients with Type 1 Diabetes Mellitus
  276. Early acute kidney injury in Northern Ireland ICUs
  277. Genetics of Diabetic Nephropathy: Are There Clues to the Understanding of Common Kidney Diseases?
  278. The Challenge of Doing What Is Right in Renal Transplantation: Balancing Equity and Utility
  279. The uptake of cervical cancer screening by renal transplant recipients
  280. Genetic association analyses of non-synonymous single nucleotide polymorphisms in diabetic nephropathy
  281. No support for association of protein kinase C, beta 1 (PRKCB1) gene promoter polymorphisms c.-1504C>T and c.-546C>G with diabetic nephropathy in Type 1 diabetes
  282. The evolution of renal transplantation in clinical practice: for better, for worse?
  283. Investigation ofAdducin 2 (beta)DNA polymorphisms in genetic predisposition to diabetic nephropathy in Type 1 diabetes
  284. Heme Oxygenase-1 Gene Promoter Polymorphisms and Outcomes of Clinical Renal Transplantation
  285. Heme Oxygenase 1: Does It Have a Role in Renal Cytoprotection?
  286. Hypokalaemic paralysis precipitated by distal renal tubular acidosis secondary to Sjögren's syndrome
  287. Critiques of Clinical Guidelines in Nephrology: Anaemia
  288. Pathophysiology of anemia and erythrocytosis
  289. Association of functional haem oxygenase-1 gene promoter polymorphism with polycystic kidney disease and IgA nephropathy
  290. The practical implications of using standardized estimation equations in calculating the prevalence of chronic kidney disease
  291. Troponin T is an independent predictor of mortality in renal transplant recipients
  292. Multiple Superoxide Dismutase 1/Splicing Factor Serine Alanine 15 Variants Are Associated With the Development and Progression of Diabetic Nephropathy: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complication...
  293. Decreased Serum Retinol Is Associated with Increased Mortality in Renal Transplant Recipients
  294. In Reply
  295. Association of VEGF-1499C→T polymorphism with diabetic nephropathy in type 1 diabetes mellitus
  296. Genetic renal abnormalities
  297. Gene discovery in diabetic nephropathy
  298. Level of renal function and serum erythropoietin levels independently predict anaemia post-renal transplantation
  299. Association of Functional Heme Oxygenase-1 Gene Promoter Polymorphism with Renal Transplantation Outcomes
  300. Warning Flags for Erythropoiesis-Stimulating Agents and Cancer-Associated Anemia
  301. Reply Orlistat and renal failure
  302. Common polymorphisms of thePAI1gene do not play a major role in the development of diabetic nephropathy in Type 1 diabetes
  303. Resequencing of genes for transforming growth factor β1 (TGFB1) type 1 and 2 receptors (TGFBR1, TGFBR2), and association analysis of variants with diabetic nephropathy
  304. Impaired Downregulation Following Erythropoietin Receptor Activation in Non-Small Cell Lung Carcinoma
  305. Are gatekeepers to renal services referring patients equitably?
  306. Association between Haptoglobin Gene Variants and Diabetic Nephropathy: Haptoglobin Polymorphism in Nephropathy Susceptibility
  307. Cost Should Be the Principal Determinant of Choice of Erythropoiesis-Stimulating Agent in Chronic Haemodialysis Patients
  308. Does angiotensin blockade influence graft outcome in renal transplant recipients with IgA nephropathy?
  309. Identifying genes for diabetic nephropathy--current difficulties and future directions
  310. Rapidly progressive renal failure associated with successful pharmacotherapy for obesity
  311. The PAX4 gene variant A1168C is not associated with early onset Type 1 diabetes in a UK population
  312. Cardiac tamponade … a wire too far?
  313. Resequencing of the characterised CTGF gene to identify novel or known variants, and analysis of their association with diabetic nephropathy
  314. A Genome-Wide DNA Microsatellite Association Screen to Identify Chromosomal Regions Harboring Candidate Genes in Diabetic Nephropathy
  315. Induction of Signalling in Non-Erythroid Cells by Pharmacological Levels of Erythropoietin
  316. Late referral for assessment of renal failure
  317. Interleukin 18 promoter polymorphisms are not strongly associated with type I diabetes in a UK population
  318. Cytokine gene polymorphisms in ischaemic heart disease: investigation using family-based tests of association
  319. Role of  -adducin DNA polymorphisms in the genetic predisposition to diabetic nephropathy
  320. Association Between Variation in the Actin-Binding Gene Caldesmon and Diabetic Nephropathy in Type 1 Diabetes
  321. Association of intercellular adhesion molecule-1 gene with type 1 diabetes
  322. Is screening for factor V leiden and prothrombin G20210A mutations in renal transplantation worthwhile? results of a large single-center U.K. study1
  323. Dialysis Clinic: Skin Thickness and Subcutaneous Erythropoietin
  324. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease
  325. Correction of anaemia with darbepoetin alfa in patients with chronic kidney disease receiving dialysis
  326. The IL12B 3′ untranslated region DNA polymorphism is not associated with early-onset type 1 diabetes
  327. EPO's Alter Ego: Erythropoietin Has Multiple Actions
  328. Novel erythropoiesis-stimulating protein in the management of the anemia of chronic renal failure
  329. A nested primer set targeting the cytomegalovirus glycoprotein B gene
  330. Influence of progressive renal dysfunction in chronic heart failure
  331. AINT/ERIC/TACC: An Expanding Family of Proteins with C-terminal Coiled Coil Domains
  332. Analysis of the association between diabetic nephropathy and polymorphisms in the aldose reductase gene in Type 1 and Type 2 diabetes mellitus
  333. Possible association between CTLA4 DNA polymorphisms and early onset type 1 diabetes in a UK population
  334. The Influence of Transforming Growth Factor-β1 Gene Polymorphisms on the Severity of Gingival Overgrowth Associated With Concomitant Use of Cyclosporin A and a Calcium Channel Blocker
  335. Characterization and localization of expression of an erythropoietin-induced gene, ERIC-1/TACC3, identified in erythroid precursor cells
  336. Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation
  337. Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation
  338. Is There an Association Between Angiotensin-Converting Enzyme Gene Variants and Chronic Nonproductive Cough?
  339. Reduction in gingival overgrowth associated with conversion from cyclosporin A to tacrolimus
  340. The calcium channel blocker used with cyclosporin has an effect on gingival overgrowth
  341. The Ferroxidase Activity of Caeruloplasmin Is Reduced in Haemodialysis Patients
  342. Allele resolution of HLA-A using oligonucleotide probes in a two-stage typing strategy
  343. Paraoxonase polymorphisms are not associated with cardiovascular risk in renal transplant recipients
  344. Erythropoietin production: evidence for multiple oxygen sensing pathways
  345. Regulation of Erythropoietin Gene Expression Depends on Two Different Oxygen-Sensing Mechanisms
  346. Improved prognosis for congenital nephrotic syndrome of the Finnish type in Irish families
  347. Homocysteine and B-group vitamins in renal transplant patients
  348. MTHFR gene polymorphism and diabetic nephropathy in type 1 diabetes
  349. Risk of developing diabetic nephropathy is not associated with synergism between the angiotensin II (type 1) receptor C1166 allele and poor glycaemic control
  350. HDL composition and HDL antioxidant capacity in patients on regular haemodialysis
  351. Plasma Glutathione Peroxidase Activity Is Reduced in Haemodialysis Patients
  352. AN INTERLUEKIN 1B ALLELE, WHICH CORRELATES WITH A HIGH SECRETOR PHENOTYPE, IS ASSOCIATED WITH DIABETIC NEPHROPATHY
  353. Sequence characterisation and expression of homeobox HOX A7 in the multi-potential erythroleukaemic cell line TF-1
  354. National scientific medical meeting 1997 abstracts
  355. Autosomal dominant Alport syndrome linked to the type IV collage  3 and  4 genes (COL4A3 and COL4A4)
  356. Up-regulation of the endothelial cell adhesion molecule intercellular adhesion molecule-1 (ICAM-1) by autoantibodies in autoimmune vasculitis
  357. Up-regulation of the granulocyte adhesion molecule Mac-1 by autoantibodies in autoimmune vasculitis
  358. A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM
  359. A Molecular Variant of Angiotensinogen Is Associated With Diabetic Nephropathy in IDDM
  360. Production and Isolation of the Recombinant N-Lobe of Human Serum Transferrin from the Methylotrophic YeastPichia pastoris
  361. LOCALIZATION OF ERYTHROPOIETIN GENE EXPRESSION IN PROXIMAL RENAL TUBULAR CELLS DETECTED BY DIGOXIGENIN‐LABELLED OLIGONUCLEOTIDE PROBES
  362. LOCALIZATION OF ERYTHROPOIETIN GENE EXPRESSION IN PROXIMAL RENAL TUBULAR CELLS DETECTED BY DIGOXIGENIN-LABELLED OLIGONUCLEOTIDE PROBES
  363. Irish nephrological society
  364. Cytosolic phospholipase A2gene expression in rat mesangial cells is regulated post-transcriptionally
  365. ACE gene typing
  366. Isolation of promoter for cytosolic phospholipase A2 (cPLA2)
  367. Reduced Phospholipase A2 Activity Is Not Accompanied by Reduced Arachidonic Acid Release
  368. Epidermal growth factor and phorbol myristate acetate increase expression of the mRNA for cytosolic phospholipase A2in glomerular mesangial cells
  369. Renal replacement therapy in multiple myeloma and systemic amyloidosis
  370. MicroCorrespondence
  371. Glomerulonephritis associated with antibodies to neutrophil cytoplasm and glomerular basement membrane.
  372. HLA antigen frequencies and Wegener's granulomatosis
  373. Outcome of pregnancy following renal transplantation
  374. Erythropoietin production in kidney tubular cells
  375. Subcutaneous Erythropoietin Therapy and Hypertensive Encephalopathy
  376. The effect of hypobaric hypoxia on misonidazole binding in normal and tumour-bearing mice
  377. Reversal of renal failure in nephritis associated with antibody to glomerular basement membrane.
  378. Assessment of cell‐mediated immunity in a British population using multiple skin test antigens